Recruitment

Recruitment Status
Unknown status

Inclusion Criteria

Negative pregnancy test result for all participating women of childbearing age;
Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
Severity score of pruritus ≥5 as defined by VAS
...
Negative pregnancy test result for all participating women of childbearing age;
Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
Severity score of pruritus ≥5 as defined by VAS
History of pruritus of >8 weeks duration.

Exclusion Criteria

Any acute illness
Inability to give informed consent
Active dermatological disorder other than UP
...
Any acute illness
Inability to give informed consent
Active dermatological disorder other than UP
Liver cirrhosis
Known poor adherence to medical recommendations
Decompensated heart failure
Known allergy to Calmmax cream

Summary

Conditions
Calmmax Cream on UP in CKD Patients.
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Single Group Assignment
  • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

Negative pregnancy test result for all participating women of childbearing age;
Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
Severity score of pruritus ≥5 as defined by VAS
...
Negative pregnancy test result for all participating women of childbearing age;
Discontinuation of any medication with presumed antipruritic effects at least 1 week before the study (including Calmmax cream)
Severity score of pruritus ≥5 as defined by VAS
History of pruritus of >8 weeks duration.

Exclusion Criteria

Any acute illness
Inability to give informed consent
Active dermatological disorder other than UP
...
Any acute illness
Inability to give informed consent
Active dermatological disorder other than UP
Liver cirrhosis
Known poor adherence to medical recommendations
Decompensated heart failure
Known allergy to Calmmax cream

Tracking Information

NCT #
NCT02032537
Collaborators
Not Provided
Investigators
  • Principal Investigator: Itzchak Slotki, MD Shaare Zedek Medical Center
  • Itzchak Slotki, MD Shaare Zedek Medical Center